Trial Details
COMPLETEDBasic Information
| Clinical ID | c1920 |
|---|---|
| Identifier | NCT03254784 |
| Trial Title | A Study to Evaluate BMS-986165 Tablet Formulation Relative to BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal and Increased Gastric pH on the BMS-986165 Tablet Formulation |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Systemic Lupus Erythematosus; Arthritic Psoriasis; Psoriasis; Inflammatory Bowel Diseases |
| Interventions | DRUG: BMS-986165 Capsule; DRUG: BMS-986165 Tablet |
Participant Information
| Sponsor | Bristol-Myers Squibb |
|---|---|
| City | Lenexa |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2017-09-13 |
|---|---|
| Primary Completion Date | 2017-11-04 |
| Completion Date | 2017-11-15 |